Built across 11 years of distributed systems architecture, Anvesh Katipelly's governance-first platform has processed ...
Continued development of OPM-101 with Phase 1 clinical validation and approval to initiate the REVERT study (Phase 1b/2a in oncology) Significant progress with OPM-201: independent validation ...